Morgan Stanley »

Tscan Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.4M 242k 5.85
2024-03-31 $1.8M 224k 7.94
2023-12-31 $1.4M 235k 5.83
2023-09-30 $664k 259k 2.56
2023-06-30 $271k 109k 2.50
2022-12-31 $65k 42k 1.55
2022-06-30 $180k 57k 3.15
2022-03-31 $134k 39k 3.42